Purchases and Sales Made in Q3 2022 in Evaxion Biotech A/S (EVAX)
This table provides information about the institutional ownership of Evaxion Biotech A/S (EVAX) during Q3 2022. The information is specifically focused on institutions that hold shares of Evaxion Biotech A/S.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
23.3K+ 27.9% |
$44.3K - $646K
|
107K
$151K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
1.55K+ 140.2% |
$2.94K - $42.8K
|
2.65K
$3.73K
|
|
|
Oct 25, 2022
Q3 2022
|
Cutler Group LP
|
BUY
|
- |
200New |
$380 - $5.54K
|
200
$282
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-600- 13.97% |
$1.14K - $16.6K
|
3.7K
$5.21K
|
|
|
Nov 17, 2022
Q3 2022
|
Telemetry Investments, L.L.C.
New York, NY |
SELL
|
- |
-93K- 76.23% |
$177K - $2.58M
|
29K
$40.9K
|